Psoriasis, with its systemic inflammatory nature ... dysfunction to improve overall patient outcomes." Co-first author Alba Lecumberri, MD, Department of Dermatology, Hospital Universitario ...

Alba Lecumberri, M.D., from the Hospital Universitario Ramón y Cajal in Madrid, and colleagues examined RI in patients with psoriasis undergoing biologic therapy in a prospective observational ...

May 27, 2025 — Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link ...

Of the total adiposity measures, including waist-to-hip ratio, abdominal fat ratio, total abdominal adipose tissue index, and waist circumference, body fat percentage was most highly associated ...

Even when medication clears skin symptoms, people with psoriasis can still have inflammation throughout their bodies that increases the risk of obesity, heart disease, and liver issues.

Accropeutics’ drug has hit the goals of a phase 2 psoriasis trial in China, prompting the biotech to pledge to “accelerate” the TYK2/JAK1 inhibitor’s clinical development. The study saw ...

Perspective from Anthony P. Fernandez, MD, PhD Residual inflammation persisted among patients with psoriasis despite optimal disease response to biologic therapies, putting them at risk for ...

Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link between central fat and ...

You may face a higher risk of developing a Candida fungus infection if you have psoriasis. This can make your psoriasis symptoms worse. It can also lead to other health issues, such as thrush or ...